Cell therapy of myocardial pathologies (Literature review)
Search for the best variant of cell therapy congestive heart failure not ischemic remains the subject of much research. The reason is the presence of factors affecting the efficiency and outcome of stem cell therapy. The most important are kind of used cell product, the way of its introduction, as well as the number of cells in the cellular product. So today there is no consensus in choosing the phenotype of the cells for cell kardioplastiki. Not defined for the most effective route of administration of cellular products. There are no data on the use of the necessary concentration of cells in the cellular product. And also there is no exact answer to the question of mechanisms of action of pluripotent cells. In this context, the analysis of available literature for answers to questions.